Skip to content

Zymeworks ZYME Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions

Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$338K+68.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$150.75K

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's unrecognized tax benefits decreases resulting from prior period tax positions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's unrecognized tax benefits decreases resulting from prior period tax positions?
Zymeworks (ZYME) reported unrecognized tax benefits decreases resulting from prior period tax positions of $0 in Q4 2025.
What does unrecognized tax benefits decreases resulting from prior period tax positions mean?
This metric represents the reduction in unrecognized tax benefits due to the settlement of tax audits or the expiration of statutes of limitations for prior periods. It indicates the resolution of tax uncertainty and the finalization of tax liabilities. Investors monitor this to gauge the release of previously reserved tax contingencies.